RESEARCH-USE BIOSIMILAR ANTIBODY
Brazikumab
Monoclonal antibody · IgG2
Brazikumab (AMG 139) is a human IgG2 monoclonal antibody, selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for the research of Crohn's disease.
TARGETIL23A
YMonoclonal antibody
CATALOGSC-BS-708
CATALOG NUMBERSC-BS-708
MOLECULAR WEIGHTApprox. 144.82 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Brazikumab (AMG 139) is a human IgG2 monoclonal antibody, selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for the research of Crohn's disease.
Brazikumab is a recombinant research-use antibody directed against IL23A.